Jennifer C Irvine

Jennifer C Irvine

UNVERIFIED PROFILE

Are you Jennifer C Irvine?   Register this Author

Register author
Jennifer C Irvine

Jennifer C Irvine

Publications by authors named "Jennifer C Irvine"

Are you Jennifer C Irvine?   Register this Author

14Publications

150Reads

40Profile Views

Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization.

Clin Sci (Lond) 2016 09 26;130(18):1629-40. Epub 2016 May 26.

Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20160097DOI Listing
September 2016

Nitroxyl donors retain their depressor effects in hypertension.

Am J Physiol Heart Circ Physiol 2013 Sep 12;305(6):H939-45. Epub 2013 Jul 12.

Department of Pharmacology, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00630.2012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761337PMC
September 2013

Nitroxyl (HNO) as a vasoprotective signaling molecule.

Antioxid Redox Signal 2011 May 2;14(9):1675-86. Epub 2010 Nov 2.

Vascular Biology and Immunopharmacology Group, Department of Pharmacology, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/ars.2010.3327DOI Listing
May 2011

Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO.

Antioxid Redox Signal 2011 May 3;14(9):1615-24. Epub 2011 Mar 3.

Department of Pharmacology, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/ars.2010.3269DOI Listing
May 2011

Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.

Pharmacol Ther 2009 Dec 29;124(3):279-300. Epub 2009 Aug 29.

Heart Failure Pharmacology, Baker IDI Heart & Diabetes Institute Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2009.08.001DOI Listing
December 2009

Nitroxyl (HNO): the Cinderella of the nitric oxide story.

Trends Pharmacol Sci 2008 Dec 1;29(12):601-8. Epub 2008 Oct 1.

Department of Pharmacology, Monash University, Clayton, VIC, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016561470800195
Publisher Site
http://dx.doi.org/10.1016/j.tips.2008.08.005DOI Listing
December 2008

Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae.

Hypertension 2007 Apr 19;49(4):885-92. Epub 2007 Feb 19.

Department of Pharmacology and Centre for Vascular Health, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.HYP.0000259328.04159.90DOI Listing
April 2007

NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.

Hypertension 2003 Jun 12;41(6):1301-7. Epub 2003 May 12.

Department of Pharmacology, Monash University, Clayton Victoria 3800, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.HYP.0000072010.54901.DEDOI Listing
June 2003